FDY.F

Healthcare Drug Manufacturers - Specialty & Generic

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

€0.28

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

294.13M

Avg Volume

EPS

-€0.01

52W High

€0.39

52W Low

€0.23

Div. Yield

0.0%

Valuation

P/B Ratio

1.02

P/S Ratio

0.44

EV/EBITDA

10.82

EV/Revenue

-1.38

Margins

Gross Margin 90.7%

Operating Margin 8.9%

Net Margin (18.9%)

EBITDA Margin (12.7%)

Growth & Returns

Revenue Growth (YoY)

6.2%

Earnings Growth (YoY)

661.9%

Earnings Growth (QoQ)

856.8%

Return on Equity

(5.7%)

Return on Assets

(3.4%)

Liquidity & Leverage

Current Ratio

6.53

Quick Ratio

6.40

Debt / Equity

0.01

Total Cash

1.22B

Total Debt

11.99M

About

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's Republic of China. It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection; doxorubicin liposome under the Libord brand; genetic engineering drugs; and oral solid preparation technology drugs. The company was founded in 1996 and is based in Shanghai, the People's Republic of China.